Clinical Research Directory
Browse clinical research sites, groups, and studies.
Neurofeedback in Clinical High Risk
Sponsor: Boston VA Research Institute, Inc.
Summary
The goal of this trial is to test whether fMRI based neurofeedback from default mode network (DMN) will reduce DMN hyperconnectivity in clinical high risk individuals, which will lead to reductions in clinical symptoms and improve cognitive performance.
Official title: Real Time Neurofeedback, Its Neurotransmitter Underpinnings, and Therapeutic Effects, in Clinical High Risk Individuals
Key Details
Gender
All
Age Range
12 Years - 30 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2024-09
Completion Date
2028-12
Last Updated
2024-07-09
Healthy Volunteers
Yes
Interventions
fMRI based neurofeedback
participants will receive neurofeedback from their brain in order to modify their own brain function